131 related articles for article (PubMed ID: 2993146)
1. Hepatocellular carcinoma in young, mentally retarded HBsAg carriers without cirrhosis.
Lohiya G; Pirkle H; Hoefs J; Lohiya S; Ngo VT
Hepatology; 1985; 5(5):824-6. PubMed ID: 2993146
[TBL] [Abstract][Full Text] [Related]
2. Hepatocellular carcinoma in hepatitis B surface antigen carriers in eight institutions.
Lohiya GS; Pirkle H; Nguyen H; Lohiya S; Vuu T
West J Med; 1988 Apr; 148(4):426-9. PubMed ID: 2838975
[TBL] [Abstract][Full Text] [Related]
3. Childhood hepatocellular carcinoma develops exclusively in hepatitis B surface antigen carriers in three decades in Taiwan. Report of 51 cases strongly associated with rapid development of liver cirrhosis.
Hsu HC; Wu MZ; Chang MH; Su IJ; Chen DS
J Hepatol; 1987 Dec; 5(3):260-7. PubMed ID: 2828461
[TBL] [Abstract][Full Text] [Related]
4. Primary hepatocellular carcinoma and hepatitis B infection during childhood.
Wu TC; Tong MJ; Hwang B; Lee SD; Hu MM
Hepatology; 1987; 7(1):46-8. PubMed ID: 2433204
[TBL] [Abstract][Full Text] [Related]
5. Liver cell dysplasia and hepatitis B surface antigen in liver cirrhosis and hepatocellular carcinoma.
Akagi G; Furuya K; Kanamura A; Chihara T; Otsuka H
Cancer; 1984 Jul; 54(2):315-8. PubMed ID: 6202391
[TBL] [Abstract][Full Text] [Related]
6. Hepatitis BeAg in chronic asymptomatic hepatitis B surface antigen carriers and in primary hepatocellular carcinoma patients.
Tswana SA
Cent Afr J Med; 1986 May; 32(5):113-6. PubMed ID: 3028639
[No Abstract] [Full Text] [Related]
7. Hepatitis B antigen in the liver in hepatocellular carcinoma in Shikoku, Japan.
Akagi G; Furuya K; Otsuka H
Cancer; 1982 Feb; 49(4):678-82. PubMed ID: 6275977
[TBL] [Abstract][Full Text] [Related]
8. Hepatocellular carcinoma in children with hepatitis B surface antigen.
Tazawa Y; Nishinomiya F; Noguchi H; Tsuchiya S; Hayashi Y; Abukawa D; Watabe M; Nakagawa M; Imaizumi M; Ohi R
Tohoku J Exp Med; 1992 May; 167(1):47-55. PubMed ID: 1333650
[TBL] [Abstract][Full Text] [Related]
9. Serum alpha fetoprotein in 714 mentally retarded carriers of hepatitis B surface antigen.
Lohiya G; Lohiya S; Fischer T; Nguyen H; Vuu T; Humerez R
Eur J Epidemiol; 1988 Jun; 4(2):181-4. PubMed ID: 2456944
[TBL] [Abstract][Full Text] [Related]
10. [Hepatitis B vaccines. An evaluation of human plasma extracted vaccines].
Prince AM; Vnek J
Fortschr Med; 1982 Oct; 100(40):1839-43. PubMed ID: 6293948
[No Abstract] [Full Text] [Related]
11. Hepatitis B virus and primary hepatocellular carcinoma: family studies in Korea.
Hann HW; Kim CY; London WT; Whitford P; Blumberg BS
Int J Cancer; 1982 Jul; 30(1):47-51. PubMed ID: 6288579
[TBL] [Abstract][Full Text] [Related]
12. Hepatitis B carriers in a centre for the mentally retarded in Finland and immunogenicity of hepatitis B vaccine.
Mölsä PK
J Ment Defic Res; 1990 Aug; 34 ( Pt 4)():379-83. PubMed ID: 2144593
[TBL] [Abstract][Full Text] [Related]
13. Tissue markers of hepatitis B virus infection in hepatocellular carcinoma and cirrhosis.
Craxi A; Pasqua P; Giannuoli G; Di Stefano R; Simonetti RG; Pagliaro L
Hepatogastroenterology; 1984 Apr; 31(2):55-9. PubMed ID: 6327478
[TBL] [Abstract][Full Text] [Related]
14. [Immunohistochemical studies on the association between hepatitis B surface antigen and primary hepatocellular carcinoma (author's transl)].
Volc-Platzer B; Hanak H; Weiss W; Denk H
Wien Klin Wochenschr; 1982 Feb; 94(4):108-14. PubMed ID: 6281995
[TBL] [Abstract][Full Text] [Related]
15. Deinstitutionalized mentally retarded hepatitis-B surface antigen carriers in public school classes: a descriptive study.
Bakal CW; Marr JS; Novick LF; Millner ES; Goldman WD; Pitkin OE
Am J Public Health; 1980 Jul; 70(7):709-11. PubMed ID: 7386705
[TBL] [Abstract][Full Text] [Related]
16. [Immunological study of carriers of Australia antigen (HBsAg)].
Rizzetto M; Verme G
Minerva Med; 1978 Aug; 69(38):2569-72. PubMed ID: 714258
[No Abstract] [Full Text] [Related]
17. The long-term serological course of asymptomatic hepatitis B virus carriers and the development of primary hepatocellular carcinoma.
Alward WL; McMahon BJ; Hall DB; Heyward WL; Francis DP; Bender TR
J Infect Dis; 1985 Apr; 151(4):604-9. PubMed ID: 2982971
[TBL] [Abstract][Full Text] [Related]
18. [Clinicopathological study of primary hepatocellular carcinoma in relation to liver cirrhosis and HBsAg (author's transl)].
Kimura H; Kako M; Torii M; Takatsuki K; Fujiwara K; Sakai T; Endo Y; Suzuki H; Oda T
Nihon Shokakibyo Gakkai Zasshi; 1979 Sep; 76(9):1836-41. PubMed ID: 229285
[No Abstract] [Full Text] [Related]
19. Clearance of hepatitis B surface antigen (HBsAg) after surgical resection of hepatocellular carcinoma.
Wu TT; Hsu HC; Chen DS; Sheu JC; Su IJ; Chen SL; Chuang SM
J Hepatol; 1987 Feb; 4(1):45-51. PubMed ID: 3033059
[TBL] [Abstract][Full Text] [Related]
20. Hepatocellular carcinoma and hepatitis B virus markers in Europe.
Vargas V; Pedreira JD; Vilaseca J; Ruiz J; Esteban R; Hernandez JM; Guardia J; Bacardi R
Lancet; 1979 Mar; 1(8118):721-2. PubMed ID: 85956
[No Abstract] [Full Text] [Related]
[Next] [New Search]
